Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Stewart

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Blood Cancer Journal|October 12, 2018
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestryLinda B Baughn, Kathryn Pearce, Dirk Larson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System LymphomasEsteban Braggio, Scott Van Wier, Juhi Ojha, et al.
Blood|September 19, 2007
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitinXinliang Mao, A Keith Stewart, Rose Hurren, et al.
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Survival and years of life lost in different age cohorts of patients with multiple myelomaHeinz Ludwig, Vanessa Bolejack, John Crowley, et al.
JAMA Oncology|January 7, 2021
Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19Alejandro Berlin, Mike Lovas, Tran Truong, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
British Journal of Haematology|February 18, 2017
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE studyMeletios A Dimopoulos, A Keith Stewart, Tamás Masszi, et al.
Blood Cancer Journal|May 22, 2023
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myelomaLinda B Baughn, Erik Jessen, Neeraj Sharma, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Blood Cancer Journal|October 12, 2018
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestryLinda B Baughn, Kathryn Pearce, Dirk Larson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System LymphomasEsteban Braggio, Scott Van Wier, Juhi Ojha, et al.
Blood|September 19, 2007
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitinXinliang Mao, A Keith Stewart, Rose Hurren, et al.
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Survival and years of life lost in different age cohorts of patients with multiple myelomaHeinz Ludwig, Vanessa Bolejack, John Crowley, et al.
JAMA Oncology|January 7, 2021
Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19Alejandro Berlin, Mike Lovas, Tran Truong, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
British Journal of Haematology|February 18, 2017
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE studyMeletios A Dimopoulos, A Keith Stewart, Tamás Masszi, et al.
Blood Cancer Journal|May 22, 2023
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myelomaLinda B Baughn, Erik Jessen, Neeraj Sharma, et al.
Pageof 21